AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05121506 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: CBD and THC with GT4 technology
Description: A single topical dose of CBD and THC will be administered with GT4 technology. The material will be provided in a single use pre-filled syringe.
Study NCT06566378 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Buzzy
Description: In children pre-procedure, buzzy was placed under the armpit. The children were made before starting the application. It continued until the end of vaccination procedure.
Study NCT06566378 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Buzzy (Placed in standard)
Description: In children pre-procedure, buzzy was placed on the arm. The children were made before starting the application. It continued until the end of vaccination procedure.
Study NCT05836025 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rapamycin
Description: 5mg/week of rapamycin orally for 12 weeks
Study NCT05836025 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 5mg/week of placebo orally for 12 weeks
Study NCT05452980 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: reestablishment of the acute angle of His
Description: A sleeve was fashioned starting 4 cm proximal to the pylorus using serial applications of an 60 stapler over a 36Fr oro-gastric bougie. A security distance of 15 mm lateral to the esophagus is respected to reduce the risk of high leak.
Study NCT05452980 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: sleeve gastrectomy
Description: A sleeve was fashioned starting 4 cm proximal to the pylorus using serial applications of an 60 stapler over a 36Fr oro-gastric bougie. A security distance of 15 mm lateral to the esophagus is respected to reduce the risk of high leak.
Study NCT06564116 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Thiomersal-free Recombinant Hepatitis E Vaccine (Escherichia Coli)
Description: Participants would receive 3 doses of thiomersal-free hepatitis E vaccine intramuscularly at month 0, 1 and 6.
Study NCT06564116 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Recombinant Hepatitis E Vaccine (Escherichia Coli)
Description: Participants would receive 3 doses of licensed hepatitis E vaccine intramuscularly at month 0, 1 and 6
Study NCT04336826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ataluren
Description: Ataluren will be administered as per the dose and schedule specified in the arm.
Study NCT06419374 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pegozafermin
Description: Subcutaneous injection
Study NCT06419374 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subcutaneous injection
Study NCT05781555 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental: DaRT seeds
Description: DaRT source will be inserted using preplanned radiotherapy parameters and reassessed by volumetric imaging 2-3 weeks after placement and then removed. The study objectives are to collect data on the general safety and efficacy of DaRT among patients who do not fit the entry criteria of existing investigational trials.
Study NCT05288348 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sufentanil 30 MCG Sublingual Tablet
Description: 30 microgram sublingual tablet administered using sublingual applicator
Study NCT05288348 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: standard care pain treatment
Description: standard care pain treatment given in Emergency Department
Study NCT06466902 — intervention group
Intervention type: OTHER
Intervention: Quality assessment of D2 lymphadenectomy using the PhotoNode Score
Description: During the surgical procedure, a set of 5 high quality laparoscopic intraoperative images of the surgical field will be put on record. Photographs will be taken at the end of the lymphadenectomy phase, before the reconstructive phase begins.~Three surgeons will review the images. Quality of D2 lymphadenectomy will be assessed independently rating eight node stations (1, 5, 6, 7, 8a, 9, 11p and 12a), based upon the evaluation of the 5 images. Each node station will be given a score from 0 to 3, corresponding to a judgment of Unevaluable (0), Poor (1), Doubtful (2) or Excellent (3) lymphadenectomy respectively, in that specific node station.~A total score for each patient will be independently obtained from each reviewer ranging from a minimum of 7 (poor lymphadenectomy) to a maximum of 24 (excellent lymphadenectomy). The PNS for each patient will originate from the average score among the three reviewers.
Study NCT04788433 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: glycomic analysis
Description: Analysis of glycans on plasma samples
Study NCT04788433 — intervention group
Intervention type: OTHER
Intervention: Phone interview
Description: patients are followed up by phone up to 1 year
Study NCT05705700 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dutasteride
Description: High dose Dutasteride (3.5 mg daily) as add-on therapy at time of PSA progression
Study NCT05705700 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abiraterone
Description: 1000 mg PO daily
Study NCT04852432 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: high flow nasal cannula
Description: The heated air is administered at a rate of 2L/kg/min using an Optiflow device (Fisher and Paykel Healthcare, Auckland, New Zealand). Inhalation oxygen concentration starts with 50%.
Study NCT04852432 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: nasal prong
Description: Oxygen is administered via nasal prong
Study NCT05723510 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tegoprazan 50mg
Description: Oral administration of one tablet of tegoprazan 50 mg once daily
Study NCT05674344 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Masimo Temperature device
Description: Non-invasive temperature device
Study NCT05020652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQ05105 tablets
Description: TQ05105 tablet is a JAK2 inhibitor, which can be used to treat JAK2 target related diseases, such as moderate or high-risk multiple myelofibrosis.
Study NCT05020652 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydroxycarbamide tablets
Description: Hydroxycarbamide tablet is a nucleoside diphosphate reductase inhibitor.
Study NCT06288776 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Herbal based mouthwash
Description: Herbal based mouthwash will be used to treat the tooth sensitivity in participants having VAS score values of tooth sensitivity ranging between 30-80
Study NCT05242549 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fitness and Nutrition Program for Seniors
Description: Fitness and Nutrition Program for Seniors uses the Trans-Theoretical Model (TTM) as the framework, which includes physical activity training, nutrition education- nursing Information, home-based training, and telecare group care (including APP assistance).~Physical activity training comprised muscle training, joint strengthening, and upper and lower limb resistance exercises for older adults who were frail. After administering nutrition education- nursing Information, participants were encouraged to set their own goals to improve their diet. Home-based training and telecare group care depends on the stages of TTM behavior change of the elderly.
Study NCT05522712 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acapella user
Description: The exercise session will include three sets of deep breaths. Each set will include 10 repetitions which were fol¬lowed by 30 to 60 seconds pause in between. Patients will be instructed to perform slow maximal inspiration, while expiration was done through acapella in a prolonged manner to minimize airway closure and alveolar collapse. In the Acapella device, resistance was increased continuously on each successive day. The technique will be applied for 15 minutes.~Components of Acapella® treatment will include :~* Breathing control~* 10 breaths through the Acapella® device~* Inhaling up to approximately three - quarter maximum breathing capacity~* 2-3 second breath hold~* Active exhalation to Functional residual capacity but not too forcefully (3-4 second)~* The patient did 2-3 huffs at the end of the session, Cough or forced expiration in a set cycle.
Study NCT05522712 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Incentive spirometer user
Description: 1. Sit upright in a chair or in bed. Hold the incentive spirometer at eye level, hold a pillow to help splint or brace the incision to decrease pain at incision.~2. Put the mouthpiece in mouth and close lips tightly around it. Slowly breathe out (exhale) completely.~3. Breathe in (inhale) slowly through mouth as deeply as possible. As taking the breath, the ball will rise.~4. Try to get the ball as high as possible.~5. When getting it, hold breath for 10 seconds, or as long as possible.~6. Then, breathe out slowly through mouth. Then, Rest for a 30-60 seconds.~7. Repeat 10 times. Try to get the ball to the same level or higher with each breath.~8. repeat 10 times for 3 sets.
Study NCT05522712 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Control
Description: This group is a control group will not receive new intervention just traditional chest physiotherapy and mobilization
Study NCT04855565 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ALY688-SR
Description: single dose subcutaneous injection
Study NCT04855565 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ALY688-SR
Description: single dose subcutaneous injection
Study NCT05723510 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Edoxaban 60mg
Description: Oral administration of one tablet of edoxaban 60 mg once daily
Study NCT05896969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SNK-396 - SAD cohort
Description: A single dose of SNK-396 within the dose range of 25 to 800 mg, or matching placebo.
Study NCT05896969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SNK-396 - MAD Cohort
Description: Multiple doses of SNK-396 within the dose range of from 25 to 800 mg, or matching placebo.
Study NCT05683210 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cup feeding
Description: The preterm infant was put on pulse oximetry and monitored, and heart rate and oxygen saturation began to be monitored. The infants' heart rate and oxygen saturation were recorded 30 minutes before feeding, and their signs of preparedness for oral feeding were monitored. After the data were recorded for 30 minutes, the infant was taken out of the incubator and his/her body weight was measured naked with only a clean diaper to determine the test weight. Feeding time was limited to 30 minutes, including the infants' resting time. When the infant was no longer sucking, the stopwatch was stopped, and the feeding phase was terminated. The feeding process was completed at the end of 30 minutes even if the infant did not take all of the food. The infant was followed up for 30 minutes after the end of feeding. During this time, the pulse oximetry continued to record and no intervention was made in order to avoid any effect on physiological values.
Study NCT05683210 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bottle feeding
Description: The preterm infant was put on pulse oximetry and monitored, and heart rate and oxygen saturation began to be monitored. The infants' heart rate and oxygen saturation were recorded 30 minutes before feeding, and their signs of preparedness for oral feeding were monitored. After the data were recorded for 30 minutes, the infant was taken out of the incubator and his/her body weight was measured naked with only a clean diaper to determine the test weight. During the feeding period, heart rate and oxygen saturation were continuously recorded. Feeding time was limited to 30 minutes, including the infants' resting time. When the infant was no longer sucking, the stopwatch was stopped, and the feeding phase was terminated. The infant was followed up for 30 minutes after the end of the feeding. During this time, the pulse oximetry continued to record and no intervention was made in order to avoid any effect on physiological values.
Study NCT05723510 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban 5mg
Description: Oral administration of one tablet of apixaban 5 mg twice daily
Study NCT05723510 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 20mg
Description: Oral administration of one tablet of rivaroxaban 20 mg once daily
Study NCT04467788 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Computer-aided sessions
Description: Changing participants' KAP of ergonomics in dentistry
Study NCT04467788 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clinical simulation sessions
Description: Changing participants' KAP of ergonomics in dentistry
Study NCT04747756 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Virtual Village
Description: The purpose of this study is to create a virtual village for people aging with HIV, and to pilot test the virtual village intervention as a final step.
Study NCT05262478 — intervention group
Intervention type: DEVICE
Intervention: Alpha-D CDP
Description: Alpha-D cervical disc prosthesis was developed jointly by the Spine Center of Koç University Faculty of Medicine and Toledo University Bioengineering Department. It was designed as a single unit to ensure user-friendly administration for surgeons, and it was designed and manufactured to reproduce the movements of the normal cervical movement segment.
Study NCT06491888 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Detection of Cervical Lesions by Fluorescence Photoelectric Image
Description: Photoelectric detection was carried out on the subjects of the experimental group.
Study NCT06554093 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Medical Device - PKS
Description: The PKS spine navigation system is for spatial positioning and orientation of surgical instruments during pedicle screw instrumentation in patients undergoing posterior fusion in single or multiple levels.
Study NCT06554093 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medical Device - PKS
Description: The PKS spine navigation system is for spatial positioning and orientation of surgical instruments during pedicle screw instrumentation in patients undergoing posterior fusion in single or multiple levels.
Study NCT04795544 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intracuff pressure measurement
Description: Intracuff pressure is measured by a pressure manometer.
Study NCT04795544 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Intracuff pressure measurement
Description: Intracuff pressure is measured by a pressure manometer.
Study NCT04807725 — intervention group
Intervention type: GENETIC
Intervention: Analysis of genetic polymorphisms
Description: For the investigation of genetic polymorphisms, it will be collected a sample of cells from the jugal mucosa with the aid of a swab. The genetic analysis will be done with the DNA extraction technique followed by PCR-RFLP techniques (polymerase chain reaction followed by restriction fragment length polymorphism).
Study NCT04807725 — intervention group
Intervention type: OTHER
Intervention: Biochemical analysis
Description: For the biochemical analysis of the inflammatory mediators IL-1beta, TNF-alpha and PGE2 a peri-implant crevicular fluid collection will be performed by inserting paper strips into peri-implant sulcus or pocket, in situations of peri-implantitis from the most affected location, while in situations of peri-implant health from the mesio-buccal location.
Study NCT05095246 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KB407 (Nebulization)
Description: Nebulized solution of KB407, a replication-incompetent HSV-1 expressing full length human CFTR
Study NCT04699903 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: POC SARS-Cov-2 IgG Antibody test
Description: All patients will undergo a Point of care (POC) SARS-Cov-2 IgG Antibody test in fingerstick whole blood
Study NCT04868006 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: End-range Maitland mobilization + proprioception training
Description: End-range Maitland mobilization performed in end position of internal rotation of the shoulder accompanied with 8--week long proprioception training
Study NCT04868006 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non end-range Maitland mobilization + proprioception training
Description: Non end-range Maitland mobilization performed in loose position of the shoulder accompanied with 8--week long proprioception training
Study NCT04868006 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham manual therapy technique + proprioception training
Description: Placebo performed in loose position of the shoulder accompanied with 8--week long proprioception training
Study NCT04983329 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Telemedicine intervention
Description: Following education, the telemedicine center will subsequently monitor operating rooms included in this trial for protocol adherence for three-months. The telemedicine center is staffed by attending anesthesiologists, resident anesthesiologists, certified registered nurse anesthetists (CRNAs) and student registered nurse anesthetists (SRNAs) and is currently providing evidence-based support to clinicians in a subset of operating rooms and post-anesthesia care unit (PACU) beds at Barnes-Jewish Hospital.
Study NCT05137509 — intervention group
Intervention type: DEVICE
Intervention: Computerized Tomography
Description: Using Computerized Tomography for diagnosis COVID -19 patients
Study NCT05195281 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fine Needle Biopsy or Aspiration
Description: A new sampling of the tumor will be performed after 4-6 months of neoadjuvant chemotherapy
Study NCT06220669 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3541860
Description: Administered IV
Study NCT05140005 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: GlowTest COVID-19 Antigen Home Test
Description: diagnostic testing for Covid 19
Study NCT06220669 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered IV
Study NCT01369316 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Circumferential Submucosal Incision Resection
Description: The patient is randomized, if in the active arm the procedure will continue as Circumferential Submucosal Incision Endoscopic Mucosal Resection.
Study NCT01369316 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic Mucosal Resection
Description: Patients randomised into this Intervention type will have Endoscopic Mucosal Resection performed
Study NCT05833893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XPO1 inhibitor
Description: COPL + XPO1 inhibitor (Selinexor, 60 mg, po., d1,8,15)
Study NCT04789642 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: blood pressure measurement whatsapp educational program
Description: educational
Study NCT05906134 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Thoracic epidural catheter
Description: The pain service and thoracic surgery attending physician will assess if the patient's pain is not well-controlled using the pain modality they are randomized to. If additional pain control is needed, this will be added as an adjunct to the study arm and will be noted in the data set. This will likely consist of a thoracic epidural catheter.
Study NCT05906134 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Local intercostal nerve block
Description: Patients receiving intercostal blocks will receive a total of 1.0 cc/kg of 0.25% Bupivacaine + epinephrine. This will be divided into two-thirds allocated for use in the chest/intercostal block and one-third allocated for use in the abdomen.
Study NCT05906134 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cryo-analgesia and intercostal nerve block
Description: The cryo-ablation will occur 2 cm from the sympathetic chain 2 intercostal spaces above and 2 intercostal spaces below the access incision. The patient will also receive a total of 1.2 cc/kg of 0.25% Bupivacaine + epinephrine. This will be divided into two-thirds allocated for use in the chest/intercostal block and one-third allocated for use in the abdomen.
Study NCT05906134 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Serratus plane catheter blocks and intercostal nerve blocks
Description: A total of 1.2 cc/kg of 0.25% Bupivacaine + epinephrine will be administered. A total of 20 cc of the weight-based calculation will be reserved for the serratus plane catheter. The remaining local anesthetic will be divided into two-thirds for the chest and one-third for the abdomen. Patients with serratus plane catheters will have an ongoing infusion of 0.2% ropivacaine at 8 ml per hour. The serratus plane catheters will also receive a bolus of 20 ml of 0.25% bupivacaine with epinephrine on POD #1, 2, 3, 4, and 5 by the pain service.
Study NCT04752579 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Pilates exercise program
Description: The program will be individually supervised and will be conducted twice a week at the physiotherapy center.~• Slow execution of 7-10 repetitions of the following Pilates exercises: Pelvic Curl, Pilates Single Legs Lifts \& Leg Change, Twist Supine Pilates exercise, Chest Lifts Pilates Exercise, Chest Lift with Rotation Pilates exercise, 100's Prep Pilates Exercise, Single Leg Stretch Pilates Exercise, Front Support Pilates Exercise and Basic Back Extension Pilates Exercise. After the 6th week, while the person will be familiar with the basic exercises of the Pilates method the following exercises will be added: Leg Pull Front, Side Bend Pilates Exercise, Sphinx - Abdominal Lift Pilates Exercise, Shoulder Bridge Prep Pilates and Shoulder Bridge Pilates Exercise. Each session will be completed with breathing exercises and stretching exercises of the torso and lower limbs for 5 minutes.